Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Plos Computational Biology|April 18, 2013
Data-driven modeling of SRC control on the mitochondrial pathway of apoptosis: implication for anticancer therapy optimizationAnnabelle Ballesta, Jonathan Lopez, Nikolay Popgeorgiev, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|April 8, 2022
Comparing the Efficiency of Online and Field-Based Outreach for the Recruitment of Black and Latino Sexual Minority Men into an HIV Prevention Implementation TrialJesse Bradford-Rogers, Jonathan Lopez-Matos, Demetria Cain, et al.
The Journal of Physical Chemistry. B|June 2, 2018
Decoding Allosteric Communication Pathways in Cyclophilin A with a Comparative Analysis of Perturbed Conformational EnsemblesIsela Rodriguez-Bussey, Xin-Qiu Yao, Abdullah Danish Shouaib, et al.
Neurocase|May 24, 2013
Influenza-associated global amnesia and hippocampal imaging abnormalityJonathan Lopez, Catherine Lomen-Hoerth, Gayle K Deutsch, et al.
Annales De Pathologie|June 10, 2018
[DICER1 mutated, solid/trabecular thyroid papillary carcinoma in an 11-year-old child]Lucie Ravella, Jonathan Lopez, Françoise Descotes, et al.
Genes|April 28, 2023
Phenotypes and Genotypes in Patients with <i>SMC1A</i>-Related Developmental and Epileptic EncephalopathyXiuhua L Bozarth, Jonathan Lopez, He Fang, et al.
Annales D'Endocrinologie|October 25, 2022
SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Role of molecular tests for cytologically indeterminate thyroid nodulesHélène Lasolle, Jonathan Lopez, François Pattou, et al.
Ecology and Evolution|October 13, 2022
Can age-related changes in parental care modulate inbreeding depression? A test using the burying beetle, <i>Nicrophorus orbicollis</i>Matthew Schrader, Parker Hughes, Samuel Jenkins, et al.
Histopathology|February 9, 2021
Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour statusNazim Benzerdjeb, Juliet Tantot, Christophe Blanchet, et al.
Cancers|February 15, 2022
PARP Inhibitors: A Major Therapeutic Option in Endocrine-Receptor Positive Breast CancersLaetitia Collet, Julien Péron, Frédérique Penault-Llorca, et al.
Pageof 11